Loading...
iAnthus Capital Holdings, Inc.
IAN.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.01
CA$0.005(100.00%)
iAnthus Capital Holdings, Inc. (IAN.CN) Financial Performance & Income Statement Overview
Review iAnthus Capital Holdings, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
5.23%
↑ 5.23%
Operating Income Growth
79.09%
↑ 79.09%
Net Income Growth
90.03%
↑ 90.03%
Operating Cash Flow Growth
315.78%
↑ 315.78%
Operating Margin
-3.39%
↓ 3.39%
Gross Margin
46.79%
↑ 46.79%
Net Profit Margin
7.01%
↑ 7.01%
ROE
-15.29%
↓ 15.29%
ROIC
-2.86%
↓ 2.86%
iAnthus Capital Holdings, Inc. (IAN.CN) Income Statement & Financial Overview
Review iAnthus Capital Holdings, Inc.'s (IAN.CN) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $38.12M | $42.72M | $40.29M | $43.00M |
| Cost of Revenue | $19.24M | $23.58M | $22.20M | $22.31M |
| Gross Profit | $18.88M | $19.14M | $18.08M | $20.69M |
| Gross Profit Ratio | $0.50 | $0.45 | $0.45 | $0.48 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $16.82M | $15.17M | $15.15M | $14.90M |
| Operating Expenses | $16.82M | $21.21M | $19.34M | $20.91M |
| Total Costs & Expenses | $36.06M | $43.55M | $41.54M | $43.22M |
| Interest Income | $0.00 | $906000.00 | $817000.00 | $2.78M |
| Interest Expense | -$4.21M | $5.63M | $5.54M | $5.41M |
| Depreciation & Amortization | $4.22M | $6.04M | $6.12M | $6.20M |
| EBITDA | $9.17M | $4.73M | $5.66M | $5.98M |
| EBITDA Ratio | $0.24 | $0.11 | $0.14 | $0.14 |
| Operating Income | -$2.01M | -$2.07M | -$1.26M | -$225000.00 |
| Operating Income Ratio | -$0.05 | -$0.05 | -$0.03 | -$0.005 |
| Other Income/Expenses (Net) | $11.17M | -$4.74M | -$4.74M | -$2.64M |
| Income Before Tax | $9.16M | -$6.81M | -$6.00M | -$2.87M |
| Income Before Tax Ratio | $0.24 | -$0.16 | -$0.15 | -$0.07 |
| Income Tax Expense | $4.009M | -$34.60M | $5.64M | $6.92M |
| Net Income | $5.15M | $27.73M | -$11.64M | -$9.79M |
| Net Income Ratio | $0.14 | $0.65 | -$0.29 | -$0.23 |
| EPS | $0.001 | $0.004 | -$0.002 | -$0.002 |
| Diluted EPS | $0.001 | $0.004 | -$0.002 | -$0.002 |
| Weighted Avg Shares Outstanding | $6.74B | $6.54B | $6.52B | $6.51B |
| Weighted Avg Shares Outstanding (Diluted) | $6.74B | $6.54B | $6.52B | $6.51B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan